Page last updated: 2024-08-21

nsc 65346 and pyrazolanthrone

nsc 65346 has been researched along with pyrazolanthrone in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jung, M; Lee, SA1

Other Studies

1 other study(ies) available for nsc 65346 and pyrazolanthrone

ArticleYear
The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin-resistant cells via protein kinase Cdelta and JNK activation.
    The Journal of biological chemistry, 2007, May-18, Volume: 282, Issue:20

    Topics: Anthracenes; Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Caspases; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Activation; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Leukemic; Humans; JNK Mitogen-Activated Protein Kinases; Lamin Type A; MAP Kinase Kinase 4; Neoplasm Proteins; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Kinase C-delta; Protein Processing, Post-Translational; Pyrimidine Nucleosides

2007